Skip to content

Protein Intake Plus Neuromuscular Electrical Stimulation on Muscle Mass in Hospitalized Elderly

Effects of Protein Intake Plus Neuromuscular Electrical Stimulation on Muscle Mass in Hospitalized Elderly: a Randomized Controlled Clinical Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05008705
Enrollment
40
Registered
2021-08-17
Start date
2021-08-25
Completion date
2025-11-01
Last updated
2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophy, Muscular

Brief summary

This study aims to investigate the effects of supplementation of protein plus sessions of electrostimulation on muscle mass, length of hospital stay, readmission and mortality of hospitalized elderly.

Detailed description

Hospitalized elderly people show malnutrition, physical inactivity, and pronounced systemic inflammation which may be exacerbated the catabolic state and promote drastic muscle wasting during the hospitalization and, thus increasing the length of stay, morbidity, and mortality. Therefore, the aim of this study is to investigate the effects of supplementation of protein plus sessions of electrostimulation on muscle mass, length of hospital stay, readmission, and mortality of hospitalized elderly.

Interventions

DIETARY_SUPPLEMENTProtein supplementation

Patients will receive diary 2 doses of the protein supplement

DEVICENeuromuscular electrostimulation.

Patients will receive diary sessions of neuromuscular electrostimulation.

DIETARY_SUPPLEMENTPlacebo (isocaloric supplement)

Patients will receive diary 2 doses of the isocaloric supplement

DEVICESham for neuromuscular electrostimulation.

Patients will not receive neuromuscular electrostimulation.

Sponsors

University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* both sex; * 65 years and older; * hospital stay less than 48 hours;

Exclusion criteria

* cancer in the last 5 years; * delirium; * cognitive deficit that impossibility the patient to read and sign the informed consent form; * neurological disease; * neurodegenerative muscular disease; * impossibility to receive the intervention.

Design outcomes

Primary

MeasureTime frameDescription
Vastus Lateralis Muscle Cross-sectional AreaFrom date of admission until the date of medical discharge. Up to 30 days.Vastus Lateralis Muscle Cross-sectional Area will be assessed through ultrasound

Secondary

MeasureTime frameDescription
Hospital readmission post-medical discharge6 months post-medical dischargeHospital readmission post-medical discharge will be the number of times that he is admitted in the hospital post-medical discharge.
Health costs6 months post-medical dischargeHealth costs will be estimated by means of the questionnaire with questions about the use of health services or equipment.
Length of hospital stayFrom date of admission until the date of medical discharge. Up to 30 days.Length of hospital stay will be the time (in days) until medical discharge.
MortalityFrom date of admission until the date of medical discharge. Up to 30 days.Mortality rate in percent
Nutritional statusFrom date of admission until the date of medical discharge. Up to 30 days.Nutritional status will be assessed through nutritional records during hospital stay
Handgrip strengthFrom date of admission until the date of medical discharge. Up to 30 days.Strength will be evaluated using handgrip strength test
Functional independenceFrom date of admission until the date of medical discharge. Up to 30 days.Functional independence will be assessed using Barthel Index
Muscle functionFrom date of admission until the date of medical discharge. Up to 30 days.Muscle function evaluated trough battery of test

Countries

Brazil

Contacts

Primary ContactHamilton Roschel, PhD
hars@usp.br+551130618789

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026